The Antiarrhythmic Efficacy of Intravenous Therapy with Disopyramide Phosphate-Reference-Cited by-同舟云学术

The Antiarrhythmic Efficacy of Intravenous Therapy with Disopyramide Phosphate

Published:1977-05 Issue:5 Volume:71 Page:597-606
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Deano Danilo A.,Wu Delon,Mautner Richard K.,Sherman Richard K.,Ehsani Ali E.,Rosen Kenneth M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference19 articles.

1. Disopyramide phosphate: Pharmacokinetic and pharmacologic relationships of a new anti-arrhythmic agent;Ranney;Arch Int Pharmacodyn Ther,1971

2. Cardiovascular effects of a newer antiarrhythmic agent, disopyramide phosphate;Mathur;Am Heart J,1972

3. Pharmacology of a new anti-arrhythmic agent, 4-diisopropyl-amino-alphaphenyl-alpha-(2 pyridyl)-butyramide (SC-7031);Mokler;J Pharmacol Exp Ther,1962

4. Clinical evaluation of a new anti-arrhythmic agent (SC-7031);Katz;Curr Ther Res,1963

5. Le traitement des troubles du rhythme cardiaque par la disopyramide;Colonna;Coeur Med Interne,1968

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disopyramide Plasma Levels in Cardiac Patients on Maintenance Therapy;Acta Medica Scandinavica;2009-04-24

2. Kinetics of Disopyramide after Intravenous Infusion to Patients with Myocardial Infarction and Heart Failure;Acta Pharmacologica et Toxicologica;2009-03-13

3. Antiarrhythmic Drug Therapy in the Management of Atrial Fibrillation;Journal of Cardiovascular Electrophysiology;1997-10

4. Indications and Limitations of Class I Drugs in Atrial Fibrillation;Pacing and Clinical Electrophysiology;1994-05

5. Efficacy of flecainide for the reversion of acute onset atrial fibrillation;The American Journal of Cardiology;1992-08